BRPI0819533A2 - Microorganismos para melhorar o estado de saúde de indivíduos com desordens relacionadas com a ingestão de glúten - Google Patents

Microorganismos para melhorar o estado de saúde de indivíduos com desordens relacionadas com a ingestão de glúten

Info

Publication number
BRPI0819533A2
BRPI0819533A2 BRPI0819533-1A2A BRPI0819533A BRPI0819533A2 BR PI0819533 A2 BRPI0819533 A2 BR PI0819533A2 BR PI0819533 A BRPI0819533 A BR PI0819533A BR PI0819533 A2 BRPI0819533 A2 BR PI0819533A2
Authority
BR
Brazil
Prior art keywords
microorganisms
individuals
health
improve
gluten ingestion
Prior art date
Application number
BRPI0819533-1A2A
Other languages
English (en)
Inventor
Sanz Herranz
Sanchez Sanchez
Medina Esther
Marcela Susana
De Palma
Inmaculada Nadal Gimenez
Original Assignee
Consejo Superior De Inventigaciones Cientificas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Consejo Superior De Inventigaciones Cientificas filed Critical Consejo Superior De Inventigaciones Cientificas
Publication of BRPI0819533A2 publication Critical patent/BRPI0819533A2/pt
Publication of BRPI0819533B1 publication Critical patent/BRPI0819533B1/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747Lactobacilli, e.g. L. acidophilus or L. brevis
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135Bacteria or derivatives thereof, e.g. probiotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745Bifidobacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Transplantation (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
BRPI0819533-1A 2007-12-24 2008-12-23 Combinação de microorganismos, uso de uma cepa, composição nutricional e farmacêutica para melhorar o estado de saúde de indivíduos com desordens relacionadas com a ingestão de glúten BRPI0819533B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ESP200703427 2007-12-24
ES200703427A ES2343499B1 (es) 2007-12-24 2007-12-24 Microorganismos para mejorar el estado de salud de individuos con desordenes relacionados con la ingesta de gluten.
PCT/ES2008/070243 WO2009080862A1 (es) 2007-12-24 2008-12-23 Microorganismos para mejorar el estado de salud de individuos con desordenes relacionados con la ingesta de gluten

Publications (2)

Publication Number Publication Date
BRPI0819533A2 true BRPI0819533A2 (pt) 2014-10-14
BRPI0819533B1 BRPI0819533B1 (pt) 2018-06-05

Family

ID=40800750

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0819533-1A BRPI0819533B1 (pt) 2007-12-24 2008-12-23 Combinação de microorganismos, uso de uma cepa, composição nutricional e farmacêutica para melhorar o estado de saúde de indivíduos com desordens relacionadas com a ingestão de glúten

Country Status (16)

Country Link
US (1) US8501169B2 (pt)
EP (1) EP2236598B1 (pt)
JP (1) JP5693232B2 (pt)
KR (1) KR20100110341A (pt)
CN (1) CN101983237B (pt)
AU (1) AU2008341708B2 (pt)
BR (1) BRPI0819533B1 (pt)
CA (1) CA2710666C (pt)
CY (1) CY1113848T1 (pt)
DK (1) DK2236598T3 (pt)
ES (2) ES2343499B1 (pt)
MX (1) MX2010007038A (pt)
PL (1) PL2236598T3 (pt)
PT (1) PT2236598E (pt)
SI (1) SI2236598T1 (pt)
WO (1) WO2009080862A1 (pt)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110081320A1 (en) * 2009-10-06 2011-04-07 Nubiome, Inc. Treatment/Cure of Autoimmune Disease
US20140187474A1 (en) * 2011-02-16 2014-07-03 The Board Of Trustees Of The Leland Stanford Junior University Therapeutic use of mucin glycans
GB201117313D0 (en) 2011-10-07 2011-11-16 Gt Biolog Ltd Bacterium for use in medicine
CN108771687A (zh) 2012-02-29 2018-11-09 伊西康内外科公司 微生物区系的组合物及与其相关的方法
GB201306536D0 (en) 2013-04-10 2013-05-22 Gt Biolog Ltd Polypeptide and immune modulation
FI127483B (en) 2014-06-11 2018-07-13 Gut Guide Oy Microbial marker for celiac disease and related product
JP6868562B2 (ja) 2014-10-31 2021-05-19 ペンデュラム セラピューティクス, インコーポレイテッド 障害の微生物的処置および診断に関する方法および組成物
EP3222281B1 (en) * 2014-11-19 2020-01-08 Kabushiki Kaisha Yakult Honsha Preventive and therapeutic agent for celiac disease
EP3193901B1 (en) 2014-12-23 2018-04-04 4D Pharma Research Limited Pirin polypeptide and immune modulation
KR20220151045A (ko) 2014-12-23 2022-11-11 4디 파마 리서치 리미티드 면역 조정
ES2575828B1 (es) * 2014-12-31 2017-07-07 Universidad De León Empleo de probióticos en el incremento de la fertilidad masculina
JP6439037B2 (ja) 2015-06-15 2018-12-19 フォーディー ファーマ リサーチ リミテッド4D Pharma Research Limited 細菌株を含む組成物
PT3240554T (pt) 2015-06-15 2019-11-04 4D Pharma Res Ltd Blautia stercosis e wexlerae para uso no tratamento de doenças inflamatórias e autoimunes
MA41010B1 (fr) 2015-06-15 2020-01-31 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
JP6426264B2 (ja) 2015-06-15 2018-11-21 フォーディー ファーマ リサーチ リミテッド4D Pharma Research Limited 細菌株を含む組成物
MA41060B1 (fr) 2015-06-15 2019-11-29 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
GB201515557D0 (en) * 2015-09-02 2015-10-14 14M Genomics Ltd Method of sequencing
GB201520497D0 (en) 2015-11-20 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
CN112569262A (zh) 2015-11-20 2021-03-30 4D制药研究有限公司 包含细菌菌株的组合物
EP3520801A1 (en) 2016-03-04 2019-08-07 4D Pharma Plc Compositions comprising bacterial blautia strains for treating visceral hypersensitivity
GB201612191D0 (en) 2016-07-13 2016-08-24 4D Pharma Plc Compositions comprising bacterial strains
EP3222282A1 (en) 2016-03-21 2017-09-27 Bionou Research, S.L. Use of probiotics in the treatment and/or prevention of psoriasis
TWI802545B (zh) 2016-07-13 2023-05-21 英商4D製藥有限公司 包含細菌菌株之組合物
EP3272396A1 (en) * 2016-07-18 2018-01-24 Bionou Research, S.L. Use of probiotics in the treatment and/or prevention of atopic dermatitis
GB201621123D0 (en) 2016-12-12 2017-01-25 4D Pharma Plc Compositions comprising bacterial strains
US20200061131A1 (en) * 2016-12-16 2020-02-27 Vedanta Biosciences, Inc. Methods and compositions for determining bacterial integrity
DK3630136T3 (da) 2017-05-22 2021-05-25 4D Pharma Res Ltd Sammensætninger, der omfatter bakteriestammer
MA41708A (fr) 2017-05-24 2020-04-08 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
PL3600363T3 (pl) 2017-06-14 2021-06-14 4D Pharma Research Limited Kompozycje zawierające szczepy bakteryjne
PT3600364T (pt) 2017-06-14 2020-10-19 4D Pharma Res Ltd Composições compreendendo uma estirpe bacteriana do género megasphera e suas utilizações
SI3638271T1 (sl) 2017-06-14 2021-01-29 4D Pharma Research Limited Sestavki, ki vsebujejo bakterijske seve
AU2018326705A1 (en) 2017-08-30 2020-03-05 Pendulum Therapeutics, Inc. Methods and compositions for treatment of microbiome-associated disorders
BR112020010929A2 (pt) 2017-12-29 2020-11-17 Société des Produits Nestlé S.A. produção de serpina
AU2019351019A1 (en) * 2018-09-27 2021-04-22 Research Development Foundation Methods and probiotic compositions for the treatment of bone disorders
US20220143143A1 (en) * 2019-02-08 2022-05-12 Mcmaster University Use of activators of the aryl hydrocarbon receptor for treating gluten-induced gastrointestinal diseases
KR20220121846A (ko) 2019-12-23 2022-09-01 에보니크 오퍼레이션즈 게엠베하 글루텐 분해를 위한 적어도 하나의 바실루스 및 락토바실루스 균주를 포함하는 박테리아 컨소시엄
CN112694992B (zh) * 2020-12-30 2023-02-21 江南大学 一株可缓解腹泻的两歧双歧杆菌及其应用
CN115400154A (zh) * 2022-08-10 2022-11-29 深圳未知君生物科技有限公司 长双歧杆菌在制备治疗自闭症谱系障碍的药物中的应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7285526B2 (en) 1995-07-14 2007-10-23 Meiogen Biotechnology Corporation Interferon antagonists useful for the treatment of interferon related diseases
ID29150A (id) * 1999-01-15 2001-08-02 Entpr Ireland Cs Penggunaan lactobacillus salivarius
US6562943B1 (en) 1999-04-21 2003-05-13 Zycos, Inc. Peptide epitopes recognized by disease promoting CD4+ T lymphocytes
PE20030284A1 (es) * 2001-07-26 2003-05-01 Alimentary Health Ltd Cepas de bifidobacterium
US7320788B2 (en) 2002-02-14 2008-01-22 The Board Of Trustees Of The Leland Stanford Junior University Enzyme treatment of foodstuffs for Celiac Sprue
ITMI20020399A1 (it) * 2002-02-28 2003-08-28 Ct Sperimentale Del Latte S P Composizioni dietetiche e/o farmaceutiche per uso umano e/o animale abase di preparati microbici probiotici
US7202216B2 (en) 2002-05-14 2007-04-10 The Board Of Trustees Of The Leland Stanford Junior University Drug therapy for celiac sprue
WO2004076615A2 (en) * 2003-02-27 2004-09-10 Bioneer A/S Immunomodulating probiotic compounds
GB0323039D0 (en) * 2003-10-01 2003-11-05 Danisco Method
US7579313B2 (en) 2003-11-18 2009-08-25 The Board Of Trustees Of The Leland Stanford Junior University Transglutaminase inhibitors and methods of use thereof
US7563864B2 (en) 2004-04-26 2009-07-21 Celiac Sprue Research Foundation Prolyl endopeptidase mediated destruction of T cell epitopes in whole gluten
WO2006097949A1 (en) * 2005-03-16 2006-09-21 Actial Farmacêutica, Lda. Mixture of at least 6 species of lactic acid bacteria and/or bifidobacteria in the manufacture of sourdough
US8071101B2 (en) 2005-11-03 2011-12-06 Avaxia Biologics, Inc. Antibody therapy for treatment of diseases associated with gluten intolerance
RU2008136208A (ru) 2006-02-09 2010-03-20 Альба Терапьютикс Корпорейшн (Us) Композиции для эффектора плотных контактов
WO2007108763A1 (en) * 2006-03-17 2007-09-27 Probac Ab Use of lactobacillus strains for promoting immunotolerance in autoimmune disease

Also Published As

Publication number Publication date
CY1113848T1 (el) 2016-07-27
JP2011507540A (ja) 2011-03-10
AU2008341708A1 (en) 2009-07-02
JP5693232B2 (ja) 2015-04-01
CA2710666A1 (en) 2009-07-02
EP2236598A4 (en) 2012-01-25
PL2236598T3 (pl) 2013-08-30
US8501169B2 (en) 2013-08-06
BRPI0819533B1 (pt) 2018-06-05
ES2343499A1 (es) 2010-08-02
US20100310520A1 (en) 2010-12-09
PT2236598E (pt) 2013-04-02
EP2236598A1 (en) 2010-10-06
WO2009080862A1 (es) 2009-07-02
ES2343499B1 (es) 2011-06-10
AU2008341708B2 (en) 2014-07-17
MX2010007038A (es) 2010-10-15
CA2710666C (en) 2018-12-04
EP2236598B1 (en) 2012-12-26
DK2236598T3 (da) 2013-04-02
KR20100110341A (ko) 2010-10-12
CN101983237B (zh) 2013-06-12
CN101983237A (zh) 2011-03-02
SI2236598T1 (sl) 2013-08-30
ES2402183T3 (es) 2013-04-29

Similar Documents

Publication Publication Date Title
BRPI0819533A2 (pt) Microorganismos para melhorar o estado de saúde de indivíduos com desordens relacionadas com a ingestão de glúten
BRPI1011089A2 (pt) Composição nutricional para estimular o desenvolvimento e a função cerebral de crianças.
BRPI0812524A2 (pt) Amidohidrolases para a preparação de gêneros alimentícios ou estimulantes
CR10075A (es) Bifenilcarboxamidas para combatir microorganismos.
PA8806501A1 (es) Triazolotriazinas y triazolopirazinas y su uso
UA16158S (uk) Сувенірна пляшка «овочева закуска»
TH84619B (th) อ่างอาบน้ำ
TH86398B (th) ปากกา
TH86399B (th) ปากกา
TH46412S1 (th) ชุดอุปกรณ์ทำความสะอาดซอกฟัน
TH95284B (th) บัลลาสท์
UA17008S (uk) Крісло м`яке
UA17010S (uk) Крісло м`яке
TH0601001328A (th) การเสริมการปล่อยสารที่ให้ประโยชน์ของผิวหนัง
TH32144S1 (th) ชิ้นส่วนอุปกรณ์สูดดม
TH92773S (th) ชิ้นส่วนอุปกรณ์สูดดม
TH89098B (th) เก้าอี้
TH89097B (th) เก้าอี้
TH97939B (th) อนุพันธ์ 1,4-ไดชัยสทิทิวเทด 3-ไซฮาโน-พิริโดน และการใช้สารเหล่านั้นเป็นสารดัดแปรพอชิทิฟ แอลโลสเทอริคของ mglur2-รีเซพเตอร์
ES1066019Y (es) Caramelo elastico
TH107814S (th) โลงศพ
TH107812S (th) โลงศพ
TH107813S (th) โลงศพ
TH107815S (th) โลงศพ
TH33709S1 (th) โลงศพ

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]